NO20070114L - Fremstilling av makromolekylaere konjugater ved firekomponent kondensasjonsreaksjon - Google Patents

Fremstilling av makromolekylaere konjugater ved firekomponent kondensasjonsreaksjon

Info

Publication number
NO20070114L
NO20070114L NO20070114A NO20070114A NO20070114L NO 20070114 L NO20070114 L NO 20070114L NO 20070114 A NO20070114 A NO 20070114A NO 20070114 A NO20070114 A NO 20070114A NO 20070114 L NO20070114 L NO 20070114L
Authority
NO
Norway
Prior art keywords
conjugates
condensation reaction
preparation
component condensation
macromolecular conjugates
Prior art date
Application number
NO20070114A
Other languages
English (en)
Norwegian (no)
Inventor
Samuel Zalipsky
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20070114L publication Critical patent/NO20070114L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyethers (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
NO20070114A 2004-06-08 2007-01-08 Fremstilling av makromolekylaere konjugater ved firekomponent kondensasjonsreaksjon NO20070114L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57819904P 2004-06-08 2004-06-08
PCT/US2005/020138 WO2005123140A2 (fr) 2004-06-08 2005-06-08 Preparation de conjugues macromoleculaires par reaction de condensation a quatre composants

Publications (1)

Publication Number Publication Date
NO20070114L true NO20070114L (no) 2007-01-08

Family

ID=35355954

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070114A NO20070114L (no) 2004-06-08 2007-01-08 Fremstilling av makromolekylaere konjugater ved firekomponent kondensasjonsreaksjon

Country Status (12)

Country Link
US (1) US7476725B2 (fr)
EP (1) EP1761282A2 (fr)
JP (1) JP2008502788A (fr)
KR (1) KR20070027621A (fr)
CN (1) CN1997401A (fr)
AU (1) AU2005253979A1 (fr)
CA (1) CA2568388A1 (fr)
IL (1) IL179303A0 (fr)
MX (1) MXPA06014307A (fr)
NO (1) NO20070114L (fr)
WO (1) WO2005123140A2 (fr)
ZA (1) ZA200609930B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470315B2 (en) 2004-04-13 2013-06-25 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
EP2007538A4 (fr) * 2006-03-31 2011-04-20 Centocor Ortho Biotech Inc Partenaires de liaison présentant des domaines d'immunoglobuline modifiés pour avoir une demi-vie plus longue
WO2007140282A1 (fr) * 2006-05-24 2007-12-06 Peg Biosciences Composés de lieurs à base de polyéthylène glycol et conjugués biologiquement actifs à base desdits composés
WO2007149594A2 (fr) 2006-06-23 2007-12-27 Quintessence Biosciences, Inc. Ribonucléases modifiées
US9175061B2 (en) 2006-07-07 2015-11-03 Novo Nordisk Health Care Ag Protein conjugates and methods for their preparation
WO2008010991A2 (fr) * 2006-07-17 2008-01-24 Quintessence Biosciences, Inc. Méthodes et compositions pour le traitement du cancer
JP2010540681A (ja) 2007-10-08 2010-12-24 クインテッセンス バイオサイエンシズ，インコーポレーテッド リボヌクレアーゼに基づく治療のための組成物及び方法
KR100967833B1 (ko) * 2008-05-20 2010-07-05 아이디비켐(주) 고순도의 폴리에틸렌글리콜 알데하이드 유도체의 제조방법
WO2010039985A1 (fr) 2008-10-01 2010-04-08 Quintessence Biosciences, Inc. Ribonucléases thérapeutiques
RU2617402C2 (ru) 2011-06-10 2017-04-25 Мерсана Терапьютикс, Инк. Конъюгаты белок-полимер-лекарственное средство
US8815226B2 (en) 2011-06-10 2014-08-26 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
JP5841768B2 (ja) * 2011-08-05 2016-01-13 花王株式会社 脂肪蓄積抑制剤

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US5103556A (en) * 1988-05-05 1992-04-14 Circon Corporation Method of manufacturing an electrohydraulic probe
US4902502A (en) * 1989-01-23 1990-02-20 Cetus Corporation Preparation of a polymer/interleukin-2 conjugate
DE69033192T3 (de) 1989-04-19 2004-05-19 Enzon, Inc. Aktive karbonate von polyalkylenoxyden zur modifizierung von polypeptiden
DE69026306T2 (de) * 1989-05-27 1996-10-17 Seikagaku Kogyo Co Ltd Verfahren für die Herstellung von Polyethylenglykolderivate und modifizierte Proteine.
JP3202744B2 (ja) * 1989-05-27 2001-08-27 住友製薬株式会社 ポリエチレングリコール誘導体を含有する蛋白質修飾試薬
US5286637A (en) * 1989-08-07 1994-02-15 Debiopharm, S.A. Biologically active drug polymer derivatives and method for preparing same
WO1992016555A1 (fr) 1991-03-18 1992-10-01 Enzon, Inc. Conjuges de polypeptides et de glycopolypeptides associes a des polymeres, contenant de l'hydrazine
US5395619A (en) * 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
SE9503380D0 (sv) * 1995-09-29 1995-09-29 Pharmacia Ab Protein derivatives
JP4410852B2 (ja) * 1996-08-02 2010-02-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 単一の共有結合ｎ末端水溶性ポリマーを有するポリペプチド
DE19636538A1 (de) 1996-09-09 1998-03-12 Bayer Ag Substituierte Aminosäurederivate
DE59810914D1 (de) 1997-05-14 2004-04-08 Morphochem Ag Verfahren zur herstellung von polymeren, die nucleobasen als seitengruppen aufweisen
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product
JP2000146971A (ja) * 1998-11-10 2000-05-26 Nisshinbo Ind Inc 生物学的活性物質の固定化用担体
TW476231B (en) * 1998-11-30 2002-02-11 Omron Tateisi Electronics Co Electronic machine
SE519326C2 (sv) 1999-11-22 2003-02-11 Astrazeneca Ab Funktionaliserade polymera reagens innefattande en syralabil isonitrildel samt förfarande för dess framställning
JP2003535208A (ja) * 2000-06-08 2003-11-25 ラ ホヤ ファーマシューティカル カンパニー 高分子量ポリエチレン・オキシドを含む多価プラットホーム分子
DE10150077B4 (de) 2001-10-10 2004-07-29 Morphochem Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung polymergebundener Isonitrile
DE10162134A1 (de) 2001-12-18 2003-07-10 Morphochem Ag Ag Fuer Kombinat Harzgebundene Isonitrile
DE10326303A1 (de) 2003-06-11 2004-12-30 Celares Gmbh Reagenzien zur Modifikation von Biopharmazeutika, deren Herstellung und Anwendung
JP2005146068A (ja) * 2003-11-13 2005-06-09 Japan Science & Technology Agency アルコキシアセチル基を構成するカルボン酸修飾されたモノメチルエーテルポリエチレングリコールポリマーの利用、前記ポリマーからの誘導体化合物類

Also Published As

Publication number Publication date
EP1761282A2 (fr) 2007-03-14
CN1997401A (zh) 2007-07-11
WO2005123140A3 (fr) 2006-08-03
US20050287113A1 (en) 2005-12-29
US7476725B2 (en) 2009-01-13
IL179303A0 (en) 2007-03-08
CA2568388A1 (fr) 2005-12-29
WO2005123140A2 (fr) 2005-12-29
KR20070027621A (ko) 2007-03-09
AU2005253979A1 (en) 2005-12-29
MXPA06014307A (es) 2007-03-12
ZA200609930B (en) 2009-01-28
JP2008502788A (ja) 2008-01-31

Similar Documents

Publication Publication Date Title
NO20070114L (no) Fremstilling av makromolekylaere konjugater ved firekomponent kondensasjonsreaksjon
AR078648A1 (es) Uso de nanotecnologia de dendrimeros para la administracion de biomoleculas en celulas vegetales
BRPI0817911B8 (pt) Processos para transferência de substâncias moleculares para dentro de células vegetais e processo para expressão de um gene
EP2415820A3 (fr) Méthode de modification de la structure moléculaire de la biomasse
EP1913940B8 (fr) Conjugues de rhein, leur procede de preparation et leurs utilisations pour preparer des medicaments permettant de traiter la nephropathie diabetique, les adherences intestinales et l'osteoarthrite
DK1940918T3 (da) Dimercaptanterminerede polythioetherpolymerer og fremgangsmåder til at fremstille og anvende samme
NO20073737L (no) Hjelp for influensavirus
BR112021018159A2 (pt) Método para gerar uma molécula de rna com atividade de silenciamento, célula geneticamente modificada, planta geneticamente modificada, célula vegetal, planta, semente, métodos de produção de uma planta, de tratamento de uma doença e de introdução da atividade de silenciamento
WO2007000343A3 (fr) Procede de fabrication de vaccins
BRPI1015952B8 (pt) Método de introdução de uma nuclease sequência-específica (ssn) em uma célula vegetal
NO20064631L (no) Konjugater av hydroksyalkylstivelse og et protein fremstilt ved reduktiv aminering
WO2007087827A8 (fr) Fabrication d'un combustible a base d'une biomasse
CY1108981T1 (el) Μεθοδος για την κατασκευη θειϊκης κυτταρινης με βελτιωμενα χαρακτηριστικα
NO20062275L (no) Fremgangsmate for a modifisere stivelse og stivelsesderivater
WO2007048089A3 (fr) Systeme a plasmides multiples de production de virus de la grippe
BRPI0413323B8 (pt) método para a preparação de uma vacina meningocócica conjugada ao toxóide tetânico em volumes comerciais
AR053827A1 (es) Composiciones de tigeciclina y metodos de preparacion
DK2294228T3 (da) Fremgangsmåde til forbehandling af planteudgangsmateriale til fremstillingen, fra sukkerholdige og lignocellulose-holdige ressourcer, af bioethanol og/eller af sukker
BRPI0719824A2 (pt) Método para produzir uma célula vegetal transgênica, uma planta ou uma parte da mesma, célula hospedeira transformada, célula vegetal transgênica, uma planta ou uma parte da mesma, semente, tecido vegetal, material de propagação, material colhido ou uma planta, e, uso de uma molécula de ácido nucleico.
NO20083198L (no) Totrinns kur polyimidoligomerer
WO2009034181A3 (fr) Procedes de preparation de microreseaux d'adn a sondes haute densite linaire
BRPI0818432A2 (pt) Bactéria fermentativa capaz de fermentar glicose, manose e xilose simultaneamente, e, processo para produzir etanol
WO2007038586A3 (fr) Procedes pour la reduction de niveaux d'impurete dans des polymeres et des produits fabriques a partir de ceux-ci
WO2006107894A8 (fr) Matiere d'oeuf liquide
FR2920311B1 (fr) Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application